Bio-View Ltd (TLV:BIOV)
5,085.00
+84.00 (1.68%)
Oct 23, 2026, 1:44 PM IDT
Bio-View Revenue
Bio-View had revenue of 10.04M ILS in the half year ending June 30, 2026, a decrease of -41.10%. This brings the company's total for the last twelve months to 20.70M, up 15.77% year-over-year. In the year 2025, Bio-View had annual revenue of 19.93M, down -22.32%. That makes Bio-View the 38,962nd largest company in the world by revenue and 402nd in Israel.
Revenue (ttm)
20.70M
Revenue Growth
+15.77%
P/S Ratio
0.32
Revenue / Employee
690.00K
Employees
31
Market Cap
6.81M
Revenue by Geography
- USA 12.77M 64.1%
- Other Countries 5.70M 28.6%
- China 1.17M 5.9%
- Israel 289.00K 1.5%
Fiscal year ended Dec 31, 2025 See the full Bio-View breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.93M | -5.73M | -22.32% |
| Dec 31, 2024 | 25.66M | -9.11M | -26.21% |
| Dec 31, 2023 | 34.77M | 5.62M | 19.29% |
| Dec 31, 2022 | 29.15M | -1.37M | -4.48% |
| Dec 31, 2021 | 30.51M | 4.55M | 17.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Rafa Laboratories | 459.86M |
| BrainsWay | 180.82M |
| Evogene | 4.94M |
| Can-Fite BioPharma | 1.21M |
| Storage Drop Storage Technologies | 31.00K |
| Imed Infinity Medical-Limited Partnership | -1.24M |